Brokers Issue Forecasts for HCA Healthcare, Inc.’s FY2024 Earnings (NYSE:HCA)

HCA Healthcare, Inc. (NYSE:HCA) – Research analysts at KeyCorp issued their FY2024 earnings estimates for shares of HCA Healthcare in a note issued to investors on Thursday, October 10th. KeyCorp analyst M. Gillmor expects that the company will earn $22.18 per share for the year. KeyCorp has a “Strong-Buy” rating on the stock. The consensus estimate for HCA Healthcare’s current full-year earnings is $22.51 per share. KeyCorp also issued estimates for HCA Healthcare’s FY2025 earnings at $25.35 EPS and FY2026 earnings at $28.13 EPS.

HCA has been the subject of a number of other reports. Deutsche Bank Aktiengesellschaft increased their target price on shares of HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research report on Friday, June 28th. Cantor Fitzgerald restated an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Leerink Partners upped their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Finally, UBS Group upped their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Five investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and four have given a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $365.65.

HCA Healthcare Stock Up 1.9 %

HCA Healthcare stock opened at $394.54 on Monday. HCA Healthcare has a twelve month low of $215.96 and a twelve month high of $409.42. The firm has a 50 day moving average price of $387.15 and a 200-day moving average price of $347.49. The company has a market capitalization of $103.34 billion, a P/E ratio of 19.67, a P/E/G ratio of 1.44 and a beta of 1.67. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. During the same period in the prior year, the firm posted $4.29 EPS. The firm’s quarterly revenue was up 10.3% compared to the same quarter last year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Stockholders of record on Monday, September 16th were given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.67%. The ex-dividend date was Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.16%.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the sale, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 17,202 shares of company stock valued at $6,407,273. Insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Bangor Savings Bank raised its holdings in HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after buying an additional 45 shares during the last quarter. MFA Wealth Advisors LLC bought a new stake in shares of HCA Healthcare in the second quarter worth approximately $27,000. Unique Wealth Strategies LLC bought a new stake in HCA Healthcare during the second quarter valued at approximately $28,000. GPS Wealth Strategies Group LLC grew its position in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after buying an additional 71 shares during the period. Finally, Benjamin F. Edwards & Company Inc. bought a new stake in HCA Healthcare during the second quarter valued at approximately $33,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.